Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 4, Open-Label Study to Evaluate Primary Adrenal Function (Glucocorticoid Axis) in Hypogonadal Men Treated With JATENZO® for 12 Months

NCT06385509 is registered in ClinicalTrials.gov with Tolmar Inc. as lead sponsor.

NCT NCT06385509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06385509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 4, Open-Label Study to Evaluate Primary Adrenal Function (Glucocorticoid Axis) in Hypogonadal Men Treated With JATENZO® for 12 Months
Lead sponsor
Tolmar Inc.
Phase
Phase 4
Overall status
Completed
Start date
July 2, 2024
Completion date
November 25, 2025
Enrollment
116 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

hypogonadism